Clinical trial

Detect V / CHEVENDO (Chemo vs. Endo)

NCT02344472

StatusUNKNOWN

Study typeINTERVENTIONAL

Start date2015-09-01

PhasePHASE3

Study timeline

Study start (actual)2015-09-01Date precision: month

Registry last updated2024-06-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Metastatic Breast Cancerunresolved

Interventions

pertuzumabDRUG · verified · RxNorm: pertuzumab

TrastuzumabDRUG · verified · RxNorm: trastuzumab

CapecitabineDRUG · verified · RxNorm: capecitabine

PaclitaxelDRUG · verified · RxNorm: paclitaxel

VinorelbineDRUG · verified · RxNorm: vinorelbine

DocetaxelDRUG · verified · RxNorm: docetaxel

ExemestaneDRUG · verified · RxNorm: exemestane

LetrozoleDRUG · verified · RxNorm: letrozole

AnastrozoleDRUG · verified · RxNorm: anastrozole

FulvestrantDRUG · verified · RxNorm: fulvestrant

RibociclibDRUG · verified · RxNorm: ribociclib

nab-PaclitaxelDRUG

eribulinDRUG · verified · RxNorm: eribulin

leuprorelinDRUG

goserelinDRUG · verified · RxNorm: goserelin

Sponsors & collaborators

Prof. Wolfgang Jannilead sponsor

Roche Pharma AGcollaborator

Novartis Pharmaceuticalscollaborator

Eisai GmbHcollaborator

Celgene Corporationcollaborator

Mapped research locations

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02344472 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.